Product Information
METOPROLOL SUCC ER 200 MG TAB is a generic product labeled by Oryza Pharmaceuticals Inc., priced at $0.1880 per EA under NDC 72516003301. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Dec 19, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Oryza Pharmaceuticals Inc.NDC
72516003301
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207206FDA Approved
12/19/2018
TE Code
AB
On Market Since
4/27/2022
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 200 MG TAB has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1880 per EA |
|---|---|
| All-time high | $0.2917 (Oct 12, 2022) |
| All-time low | $0.1284 (Nov 20, 2024) |
| 52-week high | $0.1997 |
| 52-week low | $0.1588 |
| Median price | $0.1851 |
| Average price | $0.1898 |
| Largest weekly change | +48.9% (Aug 23, 2023) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oryza Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 200 MG TAB, manufactured by Oryza Pharmaceuticals Inc., is $0.1880 per EA (NDC 72516003301), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 200 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 200 MG TAB has declined 35.5%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 200 MG TAB?
Since Sep 21, 2022, the NADAC for METOPROLOL SUCC ER 200 MG TAB has ranged from a low of $0.1284 (Nov 20, 2024) to a high of $0.2917 (Oct 12, 2022), with a median of $0.1851 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 200 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 200 MG TAB, is $0.1678 per EA — about 11% below METOPROLOL SUCC ER 200 MG TAB.
Who manufactures METOPROLOL SUCC ER 200 MG TAB?
METOPROLOL SUCC ER 200 MG TAB (NDC 72516003301) is labeled by Oryza Pharmaceuticals Inc., and CMS classifies it as a generic product.